Feed XAIR
Summary
30 / 100 · Bulios Score
Valuation 100Growth 0Profitability 0Quality 3Debt 54Stability 25
What speaks for it
- It holds more cash than debt: $5.51M against $1.43M.
- The price moves less than the market (beta 0.15).
What to watch
- The company made a loss over the last 12 months.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
2022202320242025202620272028
Diluted EPS (USD)
2022202320242025202620272028
- Analyst estimate
Revenue grew by 54% a year over 5 years.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $33.5M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $9.81M
Debt $1.43M
Free cash flow over 12 months -$19.6M
Over the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 6
- Hold 1
- Sell 0
Today's price within the analysts' price targets
Today's price $2.16 Average target $10
$2.16 $10
The average target of $10 is 363% above today's price. 86% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Business Segment 100%
By region
The company reports no revenue by region.
Business Segment brings in 100% of revenue.
Segments in detail